A detailed history of Oregon Public Employees Retirement Fund transactions in Amgen Inc stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 45,921 shares of AMGN stock, worth $12.1 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
45,921
Previous 46,070 0.32%
Holding current value
$12.1 Million
Previous $14.4 Million 2.79%
% of portfolio
0.29%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$309.38 - $337.38 $46,097 - $50,269
-149 Reduced 0.32%
45,921 $14.8 Million
Q2 2024

Aug 01, 2024

BUY
$262.75 - $319.31 $97,743 - $118,783
372 Added 0.81%
46,070 $14.4 Million
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $1.05 Million - $1.27 Million
3,920 Added 9.38%
45,698 $13 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $94,864 - $107,018
371 Added 0.9%
41,778 $12 Million
Q3 2023

Oct 26, 2023

SELL
$218.65 - $271.46 $37,607 - $46,691
-172 Reduced 0.41%
41,407 $11.1 Million
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $18.8 Million - $22.2 Million
-87,806 Reduced 67.86%
41,579 $9.23 Million
Q1 2023

May 04, 2023

BUY
$225.79 - $275.2 $432,387 - $527,008
1,915 Added 1.5%
129,385 $31.3 Million
Q4 2022

Jan 26, 2023

BUY
$229.03 - $291.01 $19.8 Million - $25.2 Million
86,580 Added 211.74%
127,470 $0
Q3 2022

Nov 01, 2022

SELL
$224.46 - $253.15 $384,051 - $433,139
-1,711 Reduced 4.02%
40,890 $9.22 Million
Q2 2022

Jul 25, 2022

SELL
$230.71 - $256.74 $16.4 Million - $18.2 Million
-70,912 Reduced 62.47%
42,601 $10.4 Million
Q1 2022

Apr 21, 2022

SELL
$219.27 - $242.57 $167,522 - $185,323
-764 Reduced 0.67%
113,513 $27.5 Million
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $1.48 Million - $1.69 Million
-7,418 Reduced 6.1%
114,277 $25.7 Million
Q3 2021

Oct 19, 2021

SELL
$212.27 - $248.7 $968,588 - $1.13 Million
-4,563 Reduced 3.61%
121,695 $25.9 Million
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $2.13 Million - $2.36 Million
9,114 Added 7.78%
126,258 $30.8 Million
Q1 2021

Apr 20, 2021

BUY
$221.91 - $258.6 $562,985 - $656,068
2,537 Added 2.21%
117,144 $29.1 Million
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $19.8 Million - $23.6 Million
-91,553 Reduced 44.41%
114,607 $26.4 Million
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $3.28 Million - $3.65 Million
-13,984 Reduced 6.35%
206,160 $52.4 Million
Q2 2020

Jul 21, 2020

BUY
$197.81 - $242.74 $16.4 Million - $20.1 Million
83,009 Added 60.53%
220,144 $51.9 Million
Q1 2020

Apr 20, 2020

SELL
$182.24 - $241.7 $1.22 Million - $1.62 Million
-6,689 Reduced 4.65%
137,135 $27.8 Million
Q4 2019

Feb 05, 2020

BUY
$189.21 - $243.2 $532,626 - $684,608
2,815 Added 2.0%
143,824 $34.7 Million
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $817,620 - $979,679
-4,696 Reduced 3.22%
141,009 $27.3 Million
Q2 2019

Jul 16, 2019

SELL
$166.7 - $195.41 $2.75 Million - $3.23 Million
-16,506 Reduced 10.18%
145,705 $26.9 Million
Q1 2019

May 07, 2019

BUY
$180.87 - $203.88 $142,525 - $160,657
788 Added 0.49%
162,211 $30.8 Million
Q4 2018

Feb 07, 2019

SELL
$178.4 - $208.25 $5.58 Billion - $6.51 Billion
-31,262,792 Reduced 99.49%
161,423 $31.4 Million
Q4 2018

Feb 05, 2019

BUY
$178.4 - $208.25 $5.58 Billion - $6.51 Billion
31,268,677 Added 20103.56%
31,424,215 $161,000
Q3 2018

Oct 30, 2018

SELL
$185.29 - $208.89 $1.09 Million - $1.23 Million
-5,879 Reduced 3.64%
155,538 $32.2 Million
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $13.7 Million - $15.4 Million
82,356 Added 104.17%
161,417 $29.8 Million
Q1 2018

Apr 12, 2018

BUY
$169.43 - $198.0 $25,922 - $30,294
153 Added 0.19%
79,061 $13.5 Million
Q4 2017

Jan 11, 2018

BUY
$168.79 - $188.59 $84,395 - $94,295
500 Added 0.64%
78,908 $0
Q3 2017

Nov 02, 2017

BUY
$167.29 - $191.0 $13.1 Million - $15 Million
78,408
78,408 $14.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.